Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF), Inc has announced the publication of a peer-reviewed research article in JAMA Otolaryngology—Head and Neck Surgery, saying the study’s findings validate the further exploration of the use of Perimeter’s wide-field Optical Coherence Tomography (WF-OCT) technology to visualize margins during head and neck surgeries.
The medical technology firm noted that the research concludes WF-OCT allowed for real-time margin visualization of excised oral and oropharyngeal tissue without impacting specimen integrity or surgical and pathology workflows.
“This publication further supports the potential use of our flagship Perimeter S-Series OCT medical imaging technology across several tissue types, including head and neck surgery,” Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) CEO Jeremy Sobotta said in a statement.
WATCH: Perimeter Medical Imaging AI aims to transform cancer surgery with its advanced imaging tools
“Further, this clinical research shows that the Perimeter OCT images correlate to histological results, with a process that does not interfere with surgical procedures or final pathology,” Sobotta added.
Perimeter added that the research study, conducted at Mount Sinai Icahn School of Medicine, included 53 adult patients undergoing primary ablative surgery of the oral cavity or oropharynx for squamous cell carcinoma (SCC).
As well, the company said resected specimens were imaged with Perimeter S-Series OCT in the operating room before routine pathology to allow for post-operative comparisons.
Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need.
Available across the US, the company’s FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level, with 10 times greater image resolution than X-ray and ultrasound, and 100 times greater than MRI.
Contact Sean at sean@proactiveinvestors.com